Ocumension Therapeutics (FRA:5DG)
Germany flag Germany · Delayed Price · Currency is EUR
0.8750
+0.0250 (2.94%)
Last updated: Nov 27, 2025, 10:30 AM CET

Ocumension Therapeutics Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 20202018 - 2019
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2018 - 2019
Cash & Equivalents
458.06769.211,0541,3141,7852,052
Upgrade
Trading Asset Securities
120.21-----
Upgrade
Cash & Short-Term Investments
578.27769.211,0541,3141,7852,052
Upgrade
Cash Growth
-40.56%-27.01%-19.83%-26.37%-12.99%64.39%
Upgrade
Accounts Receivable
149.81164.07119.36112.7118.517.81
Upgrade
Other Receivables
23.19---25.8440.75
Upgrade
Receivables
173164.07119.36112.7144.3548.56
Upgrade
Inventory
66.4245.5232.4724.14.993.03
Upgrade
Other Current Assets
---3.9--
Upgrade
Total Current Assets
817.69978.81,2061,4551,8352,103
Upgrade
Property, Plant & Equipment
468.4451.53467.65448.07365.8682.03
Upgrade
Long-Term Investments
13.9312.93364.1595272.4-
Upgrade
Other Intangible Assets
2,4942,4381,140919.05709.9725.78
Upgrade
Long-Term Deferred Charges
-----175.88
Upgrade
Other Long-Term Assets
102.9692.4393.39126.4148.25212.48
Upgrade
Total Assets
3,8973,9743,2713,0443,3312,600
Upgrade
Accounts Payable
11.7434.4225.1921.74.419.34
Upgrade
Accrued Expenses
88.2182.27100.35140.9489.0413.23
Upgrade
Short-Term Debt
--120---
Upgrade
Current Portion of Long-Term Debt
10.442.06----
Upgrade
Current Portion of Leases
11.936.8412.3312.294.191.93
Upgrade
Current Income Taxes Payable
0.291.040.341.552.41.44
Upgrade
Current Unearned Revenue
5.047.599.05---
Upgrade
Other Current Liabilities
27.0220.7948.0271.18115.8265.99
Upgrade
Total Current Liabilities
154.67155315.28247.65215.8591.93
Upgrade
Long-Term Debt
38.5314.49----
Upgrade
Long-Term Leases
22.332.395.6617.297.035.31
Upgrade
Long-Term Unearned Revenue
28.328.330.0930.09--
Upgrade
Total Liabilities
243.82200.19351.03295.04222.8897.23
Upgrade
Common Stock
0.060.060.050.050.050.04
Upgrade
Additional Paid-In Capital
8,8888,8447,6267,5117,3556,546
Upgrade
Retained Earnings
-5,003-4,876-4,722-4,447-4,045-3,785
Upgrade
Treasury Stock
-0-0-0-0-0-0
Upgrade
Comprehensive Income & Other
-232.32-194.5115.95-315.8-202.79-258.69
Upgrade
Total Common Equity
3,6533,7742,9202,7493,1082,502
Upgrade
Shareholders' Equity
3,6533,7742,9202,7493,1082,502
Upgrade
Total Liabilities & Equity
3,8973,9743,2713,0443,3312,600
Upgrade
Total Debt
83.2225.78137.9829.5811.217.24
Upgrade
Net Cash (Debt)
495.05743.42915.821,2851,7742,045
Upgrade
Net Cash Growth
-48.30%-18.82%-28.72%-27.57%-13.23%-
Upgrade
Net Cash Per Share
0.661.091.412.032.926.76
Upgrade
Filing Date Shares Outstanding
813.83815.73690.66688.74618.42591.14
Upgrade
Total Common Shares Outstanding
813.83815.73690.66688.74618.42591.14
Upgrade
Working Capital
663.02823.79890.351,2081,6192,011
Upgrade
Book Value Per Share
4.494.634.233.995.034.23
Upgrade
Tangible Book Value
1,1591,3351,7801,8302,3982,477
Upgrade
Tangible Book Value Per Share
1.421.642.582.663.884.19
Upgrade
Machinery
-394.82383.1393.7910.16.84
Upgrade
Construction In Progress
-93.5686.22323.86336.9859.03
Upgrade
Leasehold Improvements
-15.2113.499.553.612.19
Upgrade
Source: S&P Global Market Intelligence. Standard template. Financial Sources.